Date: June 24th, 2026
From: Dalhousie University
Led by Dalhousie University, BioLabs East will establish a new Good Manufacturing Practice (GMP) facility in Nova Scotia, giving academic, health care, and industry partners the specialized infrastructure needed to accelerate research toward clinical trials.
The facility will produce small batches of vaccines and cell therapies to the exacting standards required for Health Canada-authorized trials. It is part of a national effort to strengthen domestic biomanufacturing, support local sector development, and improve access to lifesaving innovations for Canadians.